16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
1989 • 8,705 citations
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
1995 • 2,390 citations
Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.
1990 • 1,510 citations
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
1995 • 1,179 citations
Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
1995 • 1,085 citations
A structural role for hormone in the thyroid hormone receptor
1995 • 938 citations
Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones.
1996 • 505 citations
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.
1995 • 502 citations
Construction of plasmids that expressE.coli β-galactosidase in mammalian cells
1989 • 458 citations
Applications of high efficiency lithium acetate transformation of intact yeast cells using single‐stranded nucleic acids as carrier
1991 • 433 citations
The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
1992 • 381 citations
Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.
1992 • 363 citations
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).
1992 • 354 citations
The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.
1994 • 343 citations
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
1990 • 333 citations
Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.
1993 • 249 citations
Identification of a New Subclass of Alu DNA Repeats Which Can Function as Estrogen Receptor-dependent Transcriptional Enhancers
1995 • 226 citations
Yeast RSP5 and Its Human Homolog hRPF1 Potentiate Hormone-Dependent Activation of Transcription by Human Progesterone and Glucocorticoid Receptors
1996 • 160 citations
A Single Amino Acid That Determines the Sensitivity of Progesterone Receptors to RU486
1992 • 141 citations
Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered Form
1989 • 138 citations
Ligand-induced Conformational Alterations of the Androgen Receptor Analyzed by Limited Trypsinization
1995 • 132 citations
Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding.
1992 • 108 citations
Identification of a negative regulatory function for steroid receptors.
1992 • 98 citations
Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells.
1994 • 92 citations
Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody.
1992 • 81 citations
The A and B Isoforms of the Human Progesterone Receptor Operate through Distinct Signaling Pathways within Target Cells
1994 • 77 citations
Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D.
1991 • 66 citations
Identification of a Transactivation Function in the Progesterone Receptor That Interacts with the TAFII110 Subunit of the TFIID Complex
1995 • 57 citations
Reversal of activity profile in analogs of the antiprogestin RU 486: effect of a 16 alpha-substituent on progestational (agonist) activity.
1993 • 20 citations